Methods for the treatment of recurrent glioblastoma (rgbm)
OwnerStanislaw R. Burzynskiinventor
Life of this patent
Estimating the term…
Abstract
Methods for the treatment of cancer, including glioblastoma multiforme (GBM) and recurrent glioblastoma multiforme (RGBM). The method includes administering to a patient a plurality of extraneous antineoplastons and a plurality of targeted agents. The plurality of extraneous antineoplastons may include two or more antineoplastons selected from phenylacetylglutaminate sodium (PG), phenylacetylisoglutaminate sodium (iso-PG), and phenylacetate (PN). The plurality of targeted agents may include two or more agents selected from bevacizumab, pazopanib, sorafenib, dasatinib, and everolimus.
Claims20
A method for treating cancer in a patient in need thereof, the method comprising administering to a patient:
- (a) a plurality of extraneous antineoplastons;
- and
- (b) a plurality of targeted agents,
- wherein the plurality of targeted agents comprises two or more agents selected from the group consisting of bevacizumab, pazopanib, sorafenib, dasatinib, and everolimus.
A method for treating cancer in a patient in need thereof, the method comprising concurrently administering to a patient:
- (a) a plurality of extraneous antineoplastons;
- (b) a plurality of targeted agents, the plurality of targeted agents comprising two or more agents selected from the group consisting of pazopanib, sorafenib, dasatinib, and everolimus;
- and
- (c) bevacizumab.
Dependencies are inferred from the claim text.